Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

U.S. coronavirus cases top 25 million: Reuters tally

Published 01/24/2021, 10:35 PM
Updated 01/24/2021, 11:20 PM
© Reuters. FILE PHOTO: A CalFire firefighter is administered his first dose of the Moderna vaccine in El Cajon, California

By Anurag Maan and Kavya B

(Reuters) - The number of coronavirus cases in the United States crossed 25 million on Sunday, a Reuters tally showed, as states accelerate their vaccine distribution and more infectious strains are found globally.

States including North Dakota and West Virginia have injected more than 83% of their allocated doses into residents' arms, according to data from the Centers for Disease Control and Prevention released on Sunday.

Virginia administered the fewest doses, with 42% of the vaccines received.

(Graphic: https://tmsnrt.rs/36802i2)

The United States has administered at least 21.8 million doses of COVID vaccines, to about 6% of its population. The two vaccines currently approved also require a second dose.

Alaska leads the vaccine administration tally, with about 13% of its population vaccinated, followed by West Virginia, with 11%.

(GRAPHIC: U.S. COVID-19 cases per capita - https://graphics.reuters.com/HEALTH-CORONAVIRUS/USA-PERCAPITA/xlbvgywyovq/chart.png)

The number of new infections is slowing after a surge following Thanksgiving and year-end holidays, with about 25% of the total U.S. COVID-19 cases recorded in the past 30 days.

An analysis of Reuters data shows it took 200 days to reach the first 5 million cases, 93 days to go from 5 million to 10 million, 31 days from 10 million to 15 million, 25 days to go from 15 million to 20 million, and 24 days to go from 20 million to 25 million cases. (Graphic: https://tmsnrt.rs/2YcdflD)

U.S. deaths have also soared this year as more than 70,000 people have lost their lives in the last 25 days, taking the toll to more than 417,000 and predicted to surpass 500,000 by February.

The number of hospitalized patients has fallen in the past 10 days and last Thursday dropped below 120,000 for the first time since Dec. 27. But some health officials are concerned the current vaccines may not work well against the South African variant of the virus.

(GRAPHIC: U.S. nears 25 million COVID-19 cases - https://graphics.reuters.com/HEALTH-CORONOVIRUS/xklvylqrrpg/chart.png)

© Reuters. FILE PHOTO:  A healthcare worker at LAC USC Medical Center tests a person at a drive through testing center during the outbreak of the coronavirus disease (COVID-19) in Los Angeles, California

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.